Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.

BRCA1/2 genes cancer predisposition hereditary cancer male breast cancer multigene panel testing multiplex ligation-dependent probe amplification next-generation sequencing

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
30 Apr 2020
Historique:
received: 31 03 2020
revised: 21 04 2020
accepted: 28 04 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 6 5 2020
Statut: epublish

Résumé

Male breast cancer (MBC) is a rare tumor, accounting for less than 1% of all breast cancers. In MBC, genetic predisposition plays an important role; however, only a few studies have investigated in depth the role of genes other than

Identifiants

pubmed: 32365798
pii: diagnostics10050269
doi: 10.3390/diagnostics10050269
pmc: PMC7277207
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cancers (Basel). 2019 Sep 11;11(9):
pubmed: 31514334
Nat Genet. 2011 Aug 28;43(10):1022-5
pubmed: 21874000
Breast Cancer Res. 2011 Feb 08;13(1):404
pubmed: 21392410
Breast Cancer Res Treat. 2010 Jul;122(1):299-301
pubmed: 20180015
J Invest Dermatol. 2014 Oct;134(10):2570-2578
pubmed: 24691054
Genes Chromosomes Cancer. 2014 Feb;53(2):177-82
pubmed: 24243779
JCO Precis Oncol. 2019 Jul 26;3:
pubmed: 32914005
Hum Mol Genet. 1997 Sep;6(9):1513-7
pubmed: 9285788
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Br J Cancer. 2012 Dec 4;107(12):2005-9
pubmed: 23099806
Breast Cancer Res Treat. 2011 Apr;126(3):771-8
pubmed: 20927582
Ann Oncol. 2013 Nov;24 Suppl 8:viii75-viii82
pubmed: 24131976
J Natl Cancer Inst. 2007 Dec 5;99(23):1811-4
pubmed: 18042939
Am J Hum Genet. 2004 Dec;75(6):1131-5
pubmed: 15492928
Breast Cancer Res. 2010;12(4):404
pubmed: 20723205
Biomed Res Int. 2013;2013:747318
pubmed: 23586058
JCO Precis Oncol. 2018 Jul 16;2:
pubmed: 32913987
JAMA. 2006 Mar 22;295(12):1379-88
pubmed: 16551709
J Med Genet. 2001 Mar;38(3):159-64
pubmed: 11238682
Oncotarget. 2017 Jul 18;8(29):47064-47075
pubmed: 28423363
Lancet. 1994 Mar 19;343(8899):692-5
pubmed: 7907678
Am J Hum Genet. 2003 Feb;72(2):270-80
pubmed: 12533788
Am Soc Clin Oncol Educ Book. 2016;35:44-56
pubmed: 27249685
Hum Mutat. 2011 Mar;32(3):325-34
pubmed: 21120943
Nat Genet. 2006 Aug;38(8):873-5
pubmed: 16832357
J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
J Natl Cancer Inst. 2005 Jun 1;97(11):813-22
pubmed: 15928302
JAMA Oncol. 2015 Oct;1(7):943-51
pubmed: 26270727
J Clin Oncol. 2014 Jul 1;32(19):2001-9
pubmed: 24733792
Breast Cancer Res. 2011 Jul 25;13(4):R73
pubmed: 21787400
Oncogene. 1998 Mar 5;16(9):1097-112
pubmed: 9528852
Genet Epidemiol. 2016 Jul;40(5):425-31
pubmed: 27112364
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Fam Cancer. 2012 Mar;11(1):41-7
pubmed: 21989927
Cancer Res. 2011 Mar 15;71(6):2222-9
pubmed: 21285249
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
Cancer Res. 1999 Jan 15;59(2):455-61
pubmed: 9927062
Int J Cancer. 2019 Jul 15;145(2):390-400
pubmed: 30613976
J Clin Oncol. 2007 Jan 1;25(1):57-63
pubmed: 16880452
Breast Cancer Res Treat. 2017 Feb;161(3):575-586
pubmed: 28008555
Am J Hum Genet. 2004 Jun;74(6):1175-82
pubmed: 15122511
J Clin Oncol. 2008 Feb 1;26(4):542-8
pubmed: 18172190
Nat Rev Cancer. 2016 Sep;16(9):599-612
pubmed: 27515922
Clin Genet. 2016 Aug;90(2):105-17
pubmed: 26662178
Int J Mol Sci. 2020 Feb 08;21(3):
pubmed: 32046255
Breast Cancer Res. 2016 Feb 09;18(1):15
pubmed: 26857456
J Natl Cancer Inst. 2014 Jan;106(1):djt361
pubmed: 24317178
N Engl J Med. 2014 Aug 7;371(6):497-506
pubmed: 25099575
Cancer Lett. 2010 Dec 8;298(2):258-63
pubmed: 20727672
Am J Hum Genet. 2009 Oct;85(4):427-46
pubmed: 19781682
Nat Genet. 2005 Dec;37(12):1315-6
pubmed: 16258541
J Natl Compr Canc Netw. 2020 Apr;18(4):380-391
pubmed: 32259785
Am J Hum Genet. 2013 Jun 6;92(6):974-80
pubmed: 23684012
Cancer. 2017 Jan 1;123(2):210-218
pubmed: 27648926
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Nat Genet. 2012 Apr 26;44(5):475-6; author reply 476
pubmed: 22538716
Cancer Res. 2004 Apr 15;64(8):2677-9
pubmed: 15087378
J Genet. 2013 Apr;92(1):131-4
pubmed: 23640417
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Lung Cancer. 2013 Apr;80(1):81-4
pubmed: 23380224
N Engl J Med. 2015 Jun 4;372(23):2243-57
pubmed: 26014596
Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):348-52
pubmed: 16492927
Nature. 1995 Dec 21-28;378(6559):789-92
pubmed: 8524414
Front Oncol. 2018 Dec 04;8:583
pubmed: 30564557
Nat Rev Cancer. 2014 Oct;14(10):643
pubmed: 25379579
Int J Cancer. 2017 Jan 1;140(1):95-102
pubmed: 27616075
N Engl J Med. 2014 Oct 23;371(17):1651-2
pubmed: 25337756
Breast Cancer Res. 2011;13(6):R119
pubmed: 22114986
PLoS One. 2012;7(4):e35295
pubmed: 22545102
J Med Genet. 2006 Nov;43(11):863-6
pubmed: 17085682
Nat Genet. 2010 May;42(5):410-4
pubmed: 20400964
J Clin Oncol. 2015 Sep 10;33(26):2901-7
pubmed: 26261251
Nature. 2014 Jan 16;505(7483):302-8
pubmed: 24429628
Fam Cancer. 2012 Jun;11(2):235-42
pubmed: 22187320
Breast. 2018 Apr;38:92-97
pubmed: 29287190
Breast Cancer Res Treat. 2018 May;169(1):105-113
pubmed: 29335925
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22
pubmed: 23628597
Breast Cancer Res Treat. 2014 Jun;145(3):625-34
pubmed: 24825132
Breast Cancer Res Treat. 2011 Apr;126(2):539-43
pubmed: 21165771
Endocr Connect. 2019 Aug;8(8):1224-1229
pubmed: 31336362
Hum Mutat. 2008 Jul;29(7):948-58
pubmed: 18431737
Fam Cancer. 2005;4(4):273-7
pubmed: 16341802
Nat Genet. 2002 May;31(1):55-9
pubmed: 11967536
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
pubmed: 10433620
J Clin Oncol. 2011 Mar 10;29(8):e191-2
pubmed: 21172876
Breast Cancer. 2020 Jul;27(4):724-731
pubmed: 32114665
J Clin Oncol. 2011 Oct 1;29(28):3747-52
pubmed: 21876083
Mol Genet Genomic Med. 2015 Sep;3(5):452-8
pubmed: 26436111
Ann Thorac Surg. 2008 Apr;85(4):1430-2
pubmed: 18355544
Br J Cancer. 2012 May 8;106(10):1697-701
pubmed: 22516946
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Science. 1994 Oct 7;266(5182):66-71
pubmed: 7545954
N Engl J Med. 2004 May 20;350(21):2129-39
pubmed: 15118073
Nature. 1984 Oct 4-10;311(5985):483-5
pubmed: 6090945
J Natl Cancer Inst. 2002 Sep 18;94(18):1358-65
pubmed: 12237281
BMC Med Genet. 2011 Jan 14;12:9
pubmed: 21232165
Fam Cancer. 2013 Sep;12(3):473-8
pubmed: 23296741
J Med Genet. 2011 Dec;48(12):860-3
pubmed: 22058428
Clin Breast Cancer. 2000 Apr;1(1):57-63; discussion 64-5
pubmed: 11899391
PLoS One. 2013;8(2):e55681
pubmed: 23409019
Science. 2007 Nov 16;318(5853):1108-13
pubmed: 17932254
J Clin Oncol. 2020 Mar 1;38(7):674-685
pubmed: 31841383
Ann Surg Oncol. 2011 Jul;18(7):1837-44
pubmed: 21484520
Br J Cancer. 2011 Oct 11;105(8):1230-4
pubmed: 21952622
Am J Hum Genet. 2003 May;72(5):1117-30
pubmed: 12677558
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12629-33
pubmed: 20616022
Am J Hum Genet. 2003 May;72(5):1308-14
pubmed: 12690581
Cancer. 2015 Jan 1;121(1):25-33
pubmed: 25186627
BMC Cancer. 2014 Jul 01;14:478
pubmed: 24986639

Auteurs

Gianluca Tedaldi (G)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Michela Tebaldi (M)

Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Valentina Zampiga (V)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Ilaria Cangini (I)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Francesca Pirini (F)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Elisa Ferracci (E)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Rita Danesi (R)

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Valentina Arcangeli (V)

Department of Medical Oncology, Ospedale Infermi, 47923 Rimini, Italy.

Mila Ravegnani (M)

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Giovanni Martinelli (G)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Fabio Falcini (F)

Romagna Cancer Registry, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Paola Ulivi (P)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Daniele Calistri (D)

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.

Classifications MeSH